Lbp Am Sa Purchases 14,621 Shares of Cardinal Health, Inc. $CAH

Key Points

• Lbp Am Sa increased its stake in Cardinal Health by 28.0% during the second quarter, acquiring an additional 14,621 shares, bringing its total holdings to 66,889 shares valued at approximately $11.24 million.
• Several institutional investors have also boosted their positions in Cardinal Health, with Wellington Management Group increasing its stake by an impressive 1,666.7% in the first quarter.
• Cardinal Health plans to pay a quarterly dividend of $0.5107 per share on October 15, with a dividend yield of 1.3% and a payout ratio of 31.63% as of the latest financials.

Lbp Am Sa lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 28.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 66,889 shares of the company's stock after buying an additional 14,621 shares during the period. Lbp Am Sa's holdings in Cardinal Health were worth $11,237,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CAH. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after buying an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI lifted its stake in shares of Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock worth $130,434,000 after buying an additional 927,950 shares in the last quarter. Nuveen LLC bought a new position in shares of Cardinal Health in the first quarter worth approximately $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new position in shares of Cardinal Health in the first quarter worth approximately $104,951,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

NYSE:CAH opened at $156.80 on Wednesday. The firm has a market capitalization of $37.25 billion, a price-to-earnings ratio of 24.31, a price-to-earnings-growth ratio of 1.31 and a beta of 0.73. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44. The business has a fifty day moving average price of $152.11 and a 200-day moving average price of $149.84.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health's revenue was up .5% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.

Insider Activity at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last 90 days. Company insiders own 0.12% of the company's stock.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of research analyst reports. Citigroup restated a "neutral" rating and set a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Evercore ISI decreased their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Robert W. Baird boosted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Bank of America boosted their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.